TOI - The Oncology Institute GAAP EPS of -$0.17 misses by $0.01 revenue of $65M misses by $3.95M
- The Oncology Institute press release ( NASDAQ: TOI ): Q3 GAAP EPS of -$0.17 misses by $0.01 .
- Revenue of $65M (+24.3% Y/Y) misses by $3.95M .
- Gross profit of $13 million, an increase of 13.8% compared to the prior year quarter
- Net loss of $2.7 million compared to net loss of $3.0 million for the prior year quarter
-
Outlook for Fiscal Year 2022- Revenue is expected to $245M to $250M vs $270.28M Consensus.
For further details see:
The Oncology Institute GAAP EPS of -$0.17 misses by $0.01, revenue of $65M misses by $3.95M